These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 7749140)
21. Expression of molecular biomarkers in primary breast tumors implanted into a surrogate host: increased levels of cyclins correlate with tumor progression. Wani G; Noyes I; Milo GE; D'Ambrosio SM Mol Med; 1997 Apr; 3(4):273-83. PubMed ID: 9131589 [TBL] [Abstract][Full Text] [Related]
22. Chromosome 11q13 abnormalities in human breast cancer. Fantl V; Smith R; Brookes S; Dickson C; Peters G Cancer Surv; 1993; 18():77-94. PubMed ID: 8013002 [TBL] [Abstract][Full Text] [Related]
23. Amplification and expression of the human cyclin D gene in esophageal cancer. Jiang W; Kahn SM; Tomita N; Zhang YJ; Lu SH; Weinstein IB Cancer Res; 1992 May; 52(10):2980-3. PubMed ID: 1533816 [TBL] [Abstract][Full Text] [Related]
24. High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1. Karlsson E; Waltersson MA; Bostner J; Pérez-Tenorio G; Olsson B; Hallbeck AL; Stål O Genes Chromosomes Cancer; 2011 Oct; 50(10):775-87. PubMed ID: 21748818 [TBL] [Abstract][Full Text] [Related]
25. Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma. Williams ME; Swerdlow SH; Rosenberg CL; Arnold A Cancer Res; 1992 Oct; 52(19 Suppl):5541s-5544s. PubMed ID: 1394169 [TBL] [Abstract][Full Text] [Related]
26. The t(11;14) (q13;q32) in multiple myeloma cell line KMS12 has its 11q13 breakpoint 330 kb centromeric from the cyclin D1 gene. Vaandrager JW; Kluin P; Schuuring E Blood; 1997 Jan; 89(1):349-50. PubMed ID: 8978314 [No Abstract] [Full Text] [Related]
27. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Callender T; el-Naggar AK; Lee MS; Frankenthaler R; Luna MA; Batsakis JG Cancer; 1994 Jul; 74(1):152-8. PubMed ID: 8004570 [TBL] [Abstract][Full Text] [Related]
28. Implication of cyclin D1 in malignant lymphoma. Callanan M; Leroux D; Magaud JP; Rimokh R Crit Rev Oncog; 1996; 7(3-4):191-203. PubMed ID: 9258602 [TBL] [Abstract][Full Text] [Related]
29. Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias. Rimokh R; Berger F; Bastard C; Klein B; French M; Archimbaud E; Rouault JP; Santa Lucia B; Duret L; Vuillaume M Blood; 1994 Jun; 83(12):3689-96. PubMed ID: 8204893 [TBL] [Abstract][Full Text] [Related]
30. Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer. Bostner J; Ahnström Waltersson M; Fornander T; Skoog L; Nordenskjöld B; Stål O Oncogene; 2007 Oct; 26(49):6997-7005. PubMed ID: 17486065 [TBL] [Abstract][Full Text] [Related]
31. Messenger RNA levels of five genes located at chromosome 11q13 in B-cell tumors with chromosome translocation t(11;14)(q13;q32). Akiyama N; Tsuruta H; Sasaki H; Sakamoto H; Hamaguchi M; Ohmura Y; Seto M; Ueda R; Hirai H; Yazaki Y Cancer Res; 1994 Jan; 54(2):377-9. PubMed ID: 8275473 [TBL] [Abstract][Full Text] [Related]
32. Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers. Brown LA; Johnson K; Leung S; Bismar TA; Benítez J; Foulkes WD; Huntsman DG Breast Cancer Res Treat; 2010 Jun; 121(2):347-54. PubMed ID: 19636701 [TBL] [Abstract][Full Text] [Related]
33. Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study. Dedes KJ; Lopez-Garcia MA; Geyer FC; Lambros MB; Savage K; Vatcheva R; Wilkerson P; Wetterskog D; Lacroix-Triki M; Natrajan R; Reis-Filho JS Breast Cancer Res Treat; 2010 Dec; 124(3):653-66. PubMed ID: 20213079 [TBL] [Abstract][Full Text] [Related]
34. Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast. Simpson JF; Quan DE; O'Malley F; Odom-Maryon T; Clarke PE Am J Pathol; 1997 Jul; 151(1):161-8. PubMed ID: 9212742 [TBL] [Abstract][Full Text] [Related]
35. Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Ormandy CJ; Musgrove EA; Hui R; Daly RJ; Sutherland RL Breast Cancer Res Treat; 2003 Apr; 78(3):323-35. PubMed ID: 12755491 [TBL] [Abstract][Full Text] [Related]
36. Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma. Williams ME; Swerdlow SH; Rosenberg CL; Arnold A Leukemia; 1993 Feb; 7(2):241-5. PubMed ID: 8426477 [TBL] [Abstract][Full Text] [Related]
38. CCND1 and FGFR1 coamplification results in the colocalization of 11q13 and 8p12 sequences in breast tumor nuclei. Bautista S; Theillet C Genes Chromosomes Cancer; 1998 Aug; 22(4):268-77. PubMed ID: 9669664 [TBL] [Abstract][Full Text] [Related]
39. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. de Boer CJ; van Krieken JH; Kluin-Nelemans HC; Kluin PM; Schuuring E Oncogene; 1995 May; 10(9):1833-40. PubMed ID: 7753558 [TBL] [Abstract][Full Text] [Related]
40. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Jiang W; Kahn SM; Zhou P; Zhang YJ; Cacace AM; Infante AS; Doi S; Santella RM; Weinstein IB Oncogene; 1993 Dec; 8(12):3447-57. PubMed ID: 8247550 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]